Confirmed Cases Of COVID-19 Variants Identified In UK - 11 June 2021
Latest updates on SARS-CoV-2 variants detected in UK.
Public Health England (PHE) releases weekly updates on the number of confirmed new cases of variants of concern and variants under investigation identified in the UK.
Rapid genotyping test speeds up availability of Delta data as cases continue to rise
Novel genotyping tests are being used to detect the Delta (VOC-21APR-02) variant, giving a result for action within 48 hours. As cases of the variant continue to rise, the tests are helping to rapidly inform public health action.
Data from these tests is available for the first time this week, as PHE figures show that cases have risen by 29,892 to 42,323.
The data indicates that over 90% of new COVID-19 cases in the UK are now the Delta variant, which continues to show a significantly higher rate of growth compared to the Alpha variant.
Positive tests identified through genotyping are subsequently confirmed through whole genome sequencing and recent data have shown them to be extremely accurate in indicating a positive variant result. This allows earlier detection of trends and improved public health response. These results have been available to Health Protection Teams for several weeks and are already being used to develop local and national activities. Most recently, the tests allowed for the early identification of rising cases in areas including Greater Manchester and Lancashire, triggering a support package to control the variant in these areas.
New research from PHE suggests that the Delta variant is associated with an approximately 60% increased risk of household transmission compared to the Alpha variant. Growth rates for Delta cases are high across the regions, with regional estimates for doubling time ranging from 4.5 days to 11.5 days
With this variant now accounting for the overwhelming majority of new cases in the UK, it is encouraging to see that the increase in cases is not yet accompanied by a similarly large increase in hospitalisations. PHE will continue to monitor closely over the next few weeks, but the data currently suggest that the vaccination programme continues to mitigate the impact of this variant in populations who have high 2 dose vaccine coverage.
Dr Jenny Harries, Chief Executive of the UK Health Security Agency, said:
"With numbers of Delta variant cases on the rise across the country, vaccination is our best defence. If you are eligible, we urge you to come forward and be vaccinated. Remember that 2 doses provide significantly more protection than a single dose.
"However, while vaccination reduces the risk of severe disease, it does not eliminate it. With data showing that Delta is significantly more transmissible than Alpha, it is just as important as ever to follow public health advice, which has not changed. Get vaccinated, work from home where you can and remember ‘hands, face, space, fresh air’ at all times. These measures work, and they save lives."